MoneyWorks4Me

The revenue slipped marginally during the September 2025 quarter. A decline of about Rs. 129.26 millions was observed as compared to Rs. 133.01 millions during the corresponding quarter last year.The Net Profit of the company registered a slight decline of -5.19% to Rs. 14.06  millions from Rs. 14.83 millions.Operating Profit saw a handsome growth to 19.46 millions from 17.43 millions in the quarter ended September 2025.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202509 202409 % Var 202509 202409 % Var 202503 202403 % Var
Sales 129.26 133.01 -2.82 237.80 251.90 -5.60 501.95 479.75 4.63
Other Income 0.55 0.81 -32.10 1.50 1.54 -2.60 3.08 3.21 -4.05
PBIDT 19.46 17.43 11.65 20.19 18.94 6.60 41.90 15.89 163.69
Interest 0.65 1.34 -51.49 1.14 2.62 -56.49 4.15 6.76 -38.61
PBDT 18.81 16.09 16.90 19.05 16.32 16.73 37.75 9.13 313.47
Depreciation 0.96 0.94 2.13 1.92 1.86 3.23 3.85 3.68 4.62
PBT 17.85 15.15 17.82 17.13 14.46 18.46 33.90 5.45 522.02
TAX 3.79 0.32 1084.38 3.51 0.40 777.50 43.69 3.01 1351.50
Deferred Tax -0.61 0.32 -290.63 -0.89 0.40 -322.50 7.88 3.01 161.79
PAT 14.06 14.83 -5.19 13.62 14.06 -3.13 -9.79 2.44 -501.23
Equity 74.20 74.20 0.00 74.20 74.20 0.00 74.20 74.20 0.00
PBIDTM(%) 15.05 13.10 14.89 8.49 7.52 12.92 8.35 3.31 152.03
Peers
Company Name CMP
Sun Pharma. Inds. 1853.30
Dr. Reddys Labs. 1202.10
Cipla 1407.65
Lupin 2085.50
Zydus Lifesciences 1195.10
View more..